alpha-naphthoflavone has been researched along with uccf-029 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fontana, G; Golding, BT; Griffin, RJ; Guiard, S; Hardcastle, IR; Leahy, JJ; Martin, N; Richardson, C; Rigoreau, L; Smith, GC; Stockley, M | 1 |
| Cui, J; Dong, J; Li, S; Meng, Q; Wang, Z | 1 |
2 other study(ies) available for alpha-naphthoflavone and uccf-029
| Article | Year |
|---|---|
Selective benzopyranone and pyrimido[2,1-a]isoquinolin-4-one inhibitors of DNA-dependent protein kinase: synthesis, structure-activity studies, and radiosensitization of a human tumor cell line in vitro.
Topics: Benzopyrans; Chromones; DNA-Activated Protein Kinase; DNA-Binding Proteins; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Isoquinolines; Morpholines; Nuclear Proteins; Protein Serine-Threonine Kinases; Pyrimidines; Radiation-Sensitizing Agents; Radiation, Ionizing; Stereoisomerism; Structure-Activity Relationship | 2005 |
Synthesis and structure-activity relationship studies of α-naphthoflavone derivatives as CYP1B1 inhibitors.
Topics: Benzoflavones; Cytochrome P-450 CYP1B1; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Molecular Docking Simulation; Molecular Structure; Recombinant Proteins; Structure-Activity Relationship | 2020 |